Kupffer cells in non-alcoholic fatty liver disease: the emerging view.
about
Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative ActivitiesOxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-AcetylcysteineKupffer cells in the liverEnergy metabolism in the liverObesity, fatty liver disease and intestinal microbiotaToxicological effect of engineered nanomaterials on the liverPathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal CellsNanoparticle Uptake: The Phagocyte ProblemHepatic toxicology following single and multiple exposure of engineered nanomaterials utilising a novel primary human 3D liver microtissue modelCLEC4F is an inducible C-type lectin in F4/80-positive cells and is involved in alpha-galactosylceramide presentation in liverCafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat dietInflammation in nonalcoholic steatohepatitis.Liver as a source for thymidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathyFructose Consumption in the Development of Obesity and the Effects of Different Protocols of Physical Exercise on the Hepatic MetabolismEvolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primatesReactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver.Contribution of gut bacteria to liver pathobiology.TLR4 and Insulin Resistance.Loss of regulator of G protein signaling 5 exacerbates obesity, hepatic steatosis, inflammation and insulin resistance.Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease.Low-level laser therapy ameliorates CCl4-induced liver cirrhosis in rats.Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in miceFXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation.Leptin in hepatocellular carcinoma.Establishment of c-myc-immortalized Kupffer cell line from a C57BL/6 mouse strain.Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice.Transcriptome analysis on the inflammatory cell infiltration of nonalcoholic steatohepatitis in bama minipigs induced by a long-term high-fat, high-sucrose diet.Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patientsCCR2 and CD44 promote inflammatory cell recruitment during fatty liver formation in a lithogenic diet fed mouse model.Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis.Inflammatory links between obesity and metabolic disease.Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell deathThe bile acid membrane receptor TGR5: a valuable metabolic target.Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice.Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory responseFatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan.NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activationTh2-associated alternative Kupffer cell activation promotes liver fibrosis without inducing local inflammation.
P2860
Q26752622-BB6167C1-6084-4921-B29A-488E87D19098Q26773384-9EED2392-7C53-4C45-9E1C-AF944408B3CBQ26822031-B7562896-FCE7-4212-8566-01B2EF2D220AQ26996783-67687E46-0B13-4C97-9E4B-BC4018C7AD4CQ26997784-224AE30C-22C8-4C9A-A97D-D8DCB729F540Q27692098-F0CCC8A3-0B11-4426-87E1-756F9BC20C41Q28071596-E13F8DCC-8D0A-41E6-8148-8CE13BE4CC2DQ28395287-BE180109-DBCA-477B-A9D1-2033654003F0Q28396392-F6FB2285-10DD-45C9-9E01-F15BA8AA4386Q28587279-35570AC8-7817-4FB1-91E6-27A895C7977DQ30399845-D9BFAD4C-6C02-41A5-BB26-FBD641971D88Q30453231-61582526-7512-4D03-A681-2F9F40EC889FQ33573502-305DA58D-331B-45DC-B3C8-2DA423E3D0DCQ33616976-C3C35190-E0A5-4753-9DC2-5F1718836E34Q33755829-32E92EE7-3207-4093-A7EC-8C0FE2F45B6CQ33879464-45DC478F-F582-46E6-AAA8-4B8D9B77992FQ33959776-6262FF8C-6CE5-41E0-94EB-97893092C65FQ34009236-6B4972ED-11DF-4258-83B5-35EBAF3A9546Q34035372-7B36B968-707A-4B3D-AF82-166D0CC0F058Q34097407-403BA036-4E02-443D-920C-86BF28A1476FQ34137610-EE89C6C0-BCA2-4257-A257-89FFC19EE9CFQ34330120-E753F58E-119A-4FD6-8363-D5D58674156BQ34349861-04FF8060-6F4A-482E-89C9-9E1D66FBA4CFQ34360710-A4CA6FF1-3940-4A93-B043-6DF8156C5990Q34366966-26E9F1B1-147A-4A61-B13F-49EDF06223AFQ34406436-AE87B433-9B45-400B-94E5-A47862F819D2Q34424719-24247FF2-AB65-406D-A99D-167BFBA43EB6Q34533851-25B0B920-775E-49C2-9DBB-53F0C12FCD9BQ34557543-E160E448-1ACB-4F28-9305-FD3F7FE3FE58Q34709831-60D125E1-BAC3-4AA6-AEFE-CD0757689205Q34769732-AFA9C8D0-DE53-448A-A88D-DE5DDA9785BEQ34876724-77977883-7F58-4294-A0A5-C940CA4A973CQ35015802-3AADD6DE-0515-4079-8F70-9D724D6DEDA1Q35061420-49FD261B-0BB8-4986-9D38-DEA03FCDD920Q35082232-FE1B2D8D-C224-43E5-9395-23383586B2C1Q35091574-5753A66F-8BB4-4ACC-9135-78AD16C0D7E5Q35183021-2D9C685B-574F-4DA5-AE6C-5A96F0F0F0A4Q35343063-46785147-F41D-45B4-AD02-2DD2F89B1072Q35408681-F3C8A246-30AC-4617-A5B1-E30B0D2A97EBQ35565153-729CACB5-14F9-4D12-A5DC-D1FDEF228583
P2860
Kupffer cells in non-alcoholic fatty liver disease: the emerging view.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Kupffer cells in non-alcoholic fatty liver disease: the emerging view.
@en
Kupffer cells in non-alcoholic fatty liver disease: the emerging view.
@nl
type
label
Kupffer cells in non-alcoholic fatty liver disease: the emerging view.
@en
Kupffer cells in non-alcoholic fatty liver disease: the emerging view.
@nl
prefLabel
Kupffer cells in non-alcoholic fatty liver disease: the emerging view.
@en
Kupffer cells in non-alcoholic fatty liver disease: the emerging view.
@nl
P2860
P1476
Kupffer cells in non-alcoholic fatty liver disease: the emerging view
@en
P2093
György Baffy
P2860
P304
P356
10.1016/J.JHEP.2009.03.008
P50
P577
2009-03-31T00:00:00Z